An uncertain future? It may be a difficult time for cardiovascular drug development, but there are still reasons to be positive, say Koos Burggraaf and Matthijs Moerland at the Centre for Human Drug Research.
An uncertain future? It may be a difficult time for cardiovascular drug development, but there are still reasons to be positive, say Koos Burggraaf and Matthijs Moerland at the Centre for Human Drug Research.